OMass Revenue and Competitors
Estimated Revenue & Valuation
- OMass's estimated annual revenue is currently $14.6M per year.
- OMass's estimated revenue per employee is $155,000
Employee Data
- OMass has 94 Employees.
- OMass grew their employee count by 16% last year.
OMass's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | SVP Finance and Operations | Reveal Email/Phone |
4 | SVP Clinical Development | Reveal Email/Phone |
5 | VP Immunology | Reveal Email/Phone |
6 | VP Medicinal Chemistry | Reveal Email/Phone |
7 | VP, Nonclinical | Reveal Email/Phone |
8 | VP, Pharmacology | Reveal Email/Phone |
9 | VP, Platforms and Founder | Reveal Email/Phone |
10 | Associate Director - Finance & Operations | Reveal Email/Phone |
OMass Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is OMass?
OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Sciences Innovation.
keywords:N/AN/A
Total Funding
94
Number of Employees
$14.6M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OMass News
Oxford, United Kingdom - 19 April 2022 - OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines...
Publication in Nature by OMass Founder, Professor Dame Carol Robinson, Shows Power of Native Mass Spectrometry in Drug Discovery by...
Oxford, United Kingdom 7 March 2022 OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines against...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.7M | 95 | 53% | N/A |
#2 | N/A | 95 | 23% | N/A |
#3 | $7.5M | 96 | 5% | N/A |
#4 | $15.2M | 98 | -26% | N/A |
#5 | $17.6M | 98 | 9% | N/A |